Annual Total Expenses
$607.70 M
+$52.46 M+9.45%
March 31, 2024
Summary
- As of February 9, 2025, TARO annual total expenses is $607.70 million, with the most recent change of +$52.46 million (+9.45%) on March 31, 2024.
- During the last 3 years, TARO annual total expenses has risen by +$203.88 million (+50.49%).
Performance
TARO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Expenses
$156.16 M
+$14.89 M+10.54%
March 31, 2024
Summary
- As of February 9, 2025, TARO quarterly total expenses is $156.16 million, with the most recent change of +$14.89 million (+10.54%) on March 31, 2024.
- Over the past year, TARO quarterly total expenses has increased by +$14.89 million (+10.54%).
Performance
TARO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TARO Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | +10.5% |
| 3 y3 years | +50.5% | +41.7% |
| 5 y5 years | +61.0% | +74.5% |
TARO Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -33.5% | -6.4% | -34.7% |
| 5 y | 5-year | at high | -37.9% | -6.4% | -43.7% |
| alltime | all time | at high | -98.6% | -6.4% | -98.1% |
Taro Pharmaceutical Industries Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $607.70 M(+9.4%) | $156.16 M(+10.5%) |
| Dec 2023 | - | $141.26 M(-1.5%) |
| Sep 2023 | - | $143.46 M(-14.0%) |
| Jun 2023 | - | $166.82 M(+21.5%) |
| Mar 2023 | $555.24 M(+27.2%) | $137.31 M(-0.4%) |
| Dec 2022 | - | $137.92 M(+0.4%) |
| Sep 2022 | - | $137.31 M(-3.8%) |
| Jun 2022 | - | $142.69 M(+17.0%) |
| Mar 2022 | $436.44 M(+8.1%) | $121.99 M(+19.6%) |
| Dec 2021 | - | $101.99 M(-3.9%) |
| Sep 2021 | - | $106.12 M(-0.2%) |
| Jun 2021 | - | $106.34 M(-3.5%) |
| Mar 2021 | $403.82 M(+1.4%) | $110.23 M(+6.2%) |
| Dec 2020 | - | $103.84 M(+1.9%) |
| Sep 2020 | - | $101.88 M(+15.9%) |
| Jun 2020 | - | $87.87 M(-25.4%) |
| Mar 2020 | $398.23 M(+5.5%) | $117.73 M(+31.6%) |
| Dec 2019 | - | $89.48 M(-9.0%) |
| Sep 2019 | - | $98.29 M(+6.0%) |
| Jun 2019 | - | $92.73 M(-14.3%) |
| Mar 2019 | $377.38 M(+5.7%) | $108.22 M(+11.1%) |
| Dec 2018 | - | $97.45 M(+21.4%) |
| Sep 2018 | - | $80.25 M(-12.3%) |
| Jun 2018 | - | $91.46 M(-8.9%) |
| Mar 2018 | $357.02 M(-2.0%) | $100.37 M(+9.3%) |
| Dec 2017 | - | $91.83 M(+13.2%) |
| Sep 2017 | - | $81.13 M(-3.1%) |
| Jun 2017 | - | $83.69 M(-11.6%) |
| Mar 2017 | $364.44 M(+8.7%) | $94.67 M(+3.6%) |
| Dec 2016 | - | $91.37 M(+4.7%) |
| Sep 2016 | - | $87.23 M(-4.3%) |
| Jun 2016 | - | $91.17 M(+9.4%) |
| Mar 2016 | $335.31 M(-1.2%) | $83.35 M(-1.9%) |
| Dec 2015 | - | $84.98 M(-1.3%) |
| Sep 2015 | - | $86.08 M(+6.4%) |
| Jun 2015 | - | $80.91 M(-10.7%) |
| Mar 2015 | $339.51 M(+4.0%) | $90.64 M(+15.6%) |
| Dec 2014 | - | $78.38 M(-11.2%) |
| Sep 2014 | - | $88.26 M(+7.3%) |
| Jun 2014 | - | $82.24 M(-4.0%) |
| Mar 2014 | $326.44 M(+5.6%) | $85.63 M(+9.6%) |
| Dec 2013 | - | $78.16 M(-5.8%) |
| Sep 2013 | - | $83.00 M(+4.2%) |
| Jun 2013 | - | $79.64 M(-0.4%) |
| Mar 2013 | $309.07 M(+291.6%) | $79.99 M(+2.1%) |
| Dec 2012 | - | $78.36 M(+11.0%) |
| Sep 2012 | - | $70.56 M(-8.2%) |
| Jun 2012 | - | $76.86 M(-2.6%) |
| Mar 2012 | $78.92 M(-73.8%) | $78.92 M(+8.3%) |
| Dec 2011 | $300.93 M(-0.8%) | $72.85 M(-4.5%) |
| Sep 2011 | - | $76.31 M(-1.4%) |
| Jun 2011 | - | $77.42 M(+4.2%) |
| Mar 2011 | - | $74.33 M(-5.2%) |
| Dec 2010 | $303.45 M(+8.1%) | $78.45 M(+0.1%) |
| Sep 2010 | - | $78.37 M(+1.8%) |
| Jun 2010 | - | $77.01 M(+10.6%) |
| Mar 2010 | - | $69.63 M(+22.9%) |
| Dec 2009 | $280.74 M | $56.64 M(-26.5%) |
| Sep 2009 | - | $77.04 M(+1.1%) |
| Jun 2009 | - | $76.18 M(+7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $70.87 M(+0.2%) |
| Dec 2008 | $282.41 M(+8.4%) | $70.74 M(-5.3%) |
| Sep 2008 | - | $74.68 M(+6.0%) |
| Jun 2008 | - | $70.44 M(-1.5%) |
| Dec 2007 | $260.49 M(-11.6%) | - |
| Dec 2006 | $294.70 M(+5.6%) | - |
| Dec 2005 | $279.08 M(-2.0%) | $71.49 M(+3.9%) |
| Sep 2005 | - | $68.79 M(-2.1%) |
| Jun 2005 | - | $70.24 M(-1.4%) |
| Mar 2005 | - | $71.27 M(-3.0%) |
| Dec 2004 | $284.65 M(+18.2%) | $73.49 M(+3.7%) |
| Sep 2004 | - | $70.87 M(+6.3%) |
| Jun 2004 | - | $66.70 M(-9.4%) |
| Mar 2004 | - | $73.58 M(+5.5%) |
| Dec 2003 | $240.77 M(+52.1%) | $69.72 M(+9.9%) |
| Sep 2003 | - | $63.46 M(+11.8%) |
| Jun 2003 | - | $56.74 M(+11.6%) |
| Mar 2003 | - | $50.85 M(+9.5%) |
| Dec 2002 | $158.32 M(+36.0%) | $46.45 M(+12.2%) |
| Sep 2002 | - | $41.41 M(+9.9%) |
| Jun 2002 | - | $37.67 M(+14.9%) |
| Mar 2002 | - | $32.80 M(+2.8%) |
| Dec 2001 | $116.45 M(+42.3%) | $31.91 M(+1.5%) |
| Sep 2001 | - | $31.45 M(+8.8%) |
| Jun 2001 | - | $28.91 M(+19.6%) |
| Mar 2001 | - | $24.18 M(+27.8%) |
| Dec 2000 | $81.83 M(+12.1%) | $18.92 M(-16.6%) |
| Sep 2000 | - | $22.69 M(+7.3%) |
| Jun 2000 | - | $21.15 M(+10.9%) |
| Mar 2000 | - | $19.08 M(-4.5%) |
| Dec 1999 | $72.97 M(+21.0%) | $19.98 M(+6.3%) |
| Sep 1999 | - | $18.80 M(+3.3%) |
| Jun 1999 | - | $18.20 M(+12.3%) |
| Mar 1999 | - | $16.20 M(+25.6%) |
| Dec 1998 | $60.30 M(+6.0%) | - |
| Mar 1998 | - | $12.90 M(-15.1%) |
| Dec 1997 | $56.90 M(+10.1%) | $15.20 M(+2.0%) |
| Sep 1997 | - | $14.90 M(+2.8%) |
| Jun 1997 | - | $14.50 M(+19.8%) |
| Mar 1997 | - | $12.10 M(-12.3%) |
| Dec 1996 | $51.70 M(+16.7%) | $13.80 M(+3.8%) |
| Sep 1996 | - | $13.30 M(+5.6%) |
| Jun 1996 | - | $12.60 M(+5.0%) |
| Mar 1996 | - | $12.00 M(+64.4%) |
| Dec 1995 | $44.30 M(+26.6%) | - |
| Dec 1994 | $35.00 M(+29.2%) | - |
| Dec 1993 | $27.10 M(+10.2%) | - |
| Dec 1992 | $24.60 M(+39.0%) | $7.30 M(+14.1%) |
| Sep 1992 | - | $6.40 M(+8.5%) |
| Jun 1992 | - | $5.90 M(+20.4%) |
| Mar 1992 | - | $4.90 M(+8.9%) |
| Dec 1991 | $17.70 M(+42.7%) | $4.50 M(-11.8%) |
| Sep 1991 | - | $5.10 M(+24.4%) |
| Jun 1991 | - | $4.10 M(+2.5%) |
| Mar 1991 | - | $4.00 M(+33.3%) |
| Dec 1990 | $12.40 M(+9.7%) | - |
| Mar 1990 | - | $3.00 M |
| Dec 1989 | $11.30 M(+27.0%) | - |
| Dec 1988 | $8.90 M(+4.7%) | - |
| Dec 1987 | $8.50 M | - |
FAQ
- What is Taro Pharmaceutical Industries annual total expenses?
- What is the all time high annual total expenses for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual total expenses year-on-year change?
- What is Taro Pharmaceutical Industries quarterly total expenses?
- What is the all time high quarterly total expenses for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly total expenses year-on-year change?
What is Taro Pharmaceutical Industries annual total expenses?
The current annual total expenses of TARO is $607.70 M
What is the all time high annual total expenses for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual total expenses is $607.70 M
What is Taro Pharmaceutical Industries annual total expenses year-on-year change?
Over the past year, TARO annual total expenses has changed by +$52.46 M (+9.45%)
What is Taro Pharmaceutical Industries quarterly total expenses?
The current quarterly total expenses of TARO is $156.16 M
What is the all time high quarterly total expenses for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly total expenses is $166.82 M
What is Taro Pharmaceutical Industries quarterly total expenses year-on-year change?
Over the past year, TARO quarterly total expenses has changed by +$14.89 M (+10.54%)